Abstract:Background: Painful diabetic neuropathy (PDN) is a common complication secondary to diabetes mellitus. Nav1.8 is an isoform of voltage-gated sodium channels and its expression regulation is closely related with PDN. MicroRNA-145 (miR-145) is involved in the occurrence and development of neuropathic pain. TargetScan software has revealed that Nav1.8 (SCN10A) is the major target of miR-145. However, its function between miR-145 and Nav1.8 in PDN is unknown. Objectives: We aim to explore the regulatory effect of miR-145 on the expression and function of Nav1.8, which plays a pivotal role in precluding the advancement of neuropathic mechanical hyperalgesia in diabetic pain. Study Design: An experimental, animal study. Setting: An animal research facility at Nanjing Maternal and Child Health Institute, China. Methods: The paw mechanical withdrawal threshold (PMWT) of rats was assessed with the von Frey test. The adverse regulation of Nav1.8 by miR-145 was confirmed by a dual luciferase detection system in HEK293T cells. The mRNA level and expression of Nav1.8 in dorsal root ganglion (DRG) neurons were assessed with real-time polymerase chain reaction (real-time PCR), western blotting and immunofluorescence assays following intrathecal injection of agomiR-145 in vitro and in vivo. Whole-cell patch-clamping was applied to assess alterations in the tetrodotoxin-resistant (TTX-R) sodium current (Nav1.8) in DRGs. Results: The PMWT was significantly decreased in rats following streptozotocin (STZ) injection on Day 7 and was maintained at a lower level on Day 28; this change was accompanied by changes in the expression of Nav1.8 in DRG neurons, which was increased 3 days after STZ injection and reached a maximal level on Day 14. The early knockdown of Nav1.8 with siRNA or agomiR-145 treatment on Day 8 effectively precluded the deterioration of pain behaviors in STZ-treated rats. The luciferase intensity was significantly decreased in HEK293T cells expressing wild-type SCN10A infected with miR-145 mimic. In addition, Nav1.8 overexpression was significantly repressed via overexpression of miR-145 in cultured DRG neurons, and neuronal hyperexcitability was concomitantly decreased. Furthermore, the intrathecal administration of agomiR-145 elicited a significant decrease in Nav1.8 expression in DRG neurons from STZ-treated rats on Day 14. Limitations: The causes of PDN are likely to be multifactorial and inflammatory markers, such as IL-6, IL-2, and TNF-alpha, are elevated in hyperglycemia and might be the precipitating factors that contribute to miR-145 dysregulation. The curative effect of miR-145 upregulation in reversal of pain behaviors at the stage of well-established PDN wasn't investigated in this study. Conclusion: Early infection with a lentiviral vector overexpressing miR-145 adversely regulated the expression and function of TTX-resistant Nav1.8 and abrogated the development of PDN. Therefore, miR-145 might be a potential therapeutic target for preventing PDN in the near future.

The role of TNF-alpha/NF-kappa B pathway on the up-regulation of voltage-gated sodium channel Nav1.7 in DRG neurons of rats with diabetic neuropathy.

TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury

Effect of TNF-α on Expression of Nav1.3 Channels in Dorsal Root Ganglion

Upregulation of Nav1.3 Channel Induced by Rrtnf in Cultured Adult Rat DRG Neurons Via P38 MAPK and JNK Pathways.

TNF-α/STAT3 pathway epigenetically upregulates Nav1.6 expression in DRG and contributes to neuropathic pain induced by L5-VRT

Sodium Channel Nav1.6 is Up-Regulated in the Dorsal Root Ganglia in a Mouse Model of Type 2 Diabetes

Axotomy-Induced Up-Regulation of Tumor Necrosis Factor-Alpha in the Dorsal Root Ganglia

Inhibition of NF-kappaB Prevents Mechanical Allodynia Induced by Spinal Ventral Root Transection and Suppresses the Re-Expression of Nav1.3 in DRG Neurons in Vivo and in Vitro.

Voltage‐gated Sodium Channel 1.7 Expression Decreases in Dorsal Root Ganglia in a Spinal Nerve Ligation Neuropathic Pain Model

Functional Upregulation of Nav1.8 Sodium Channels on the Membrane of Dorsal Root Ganglia Neurons Contributes to the Development of Cancer-Induced Bone Pain

Role of TLR4/NF-κB Signaling Pathway in Development of Postoperative Chronic Pain in Rats: the Relationship with Expression of Nav 1. 7 in Dorsal Root Ganglion

Netrin-3 Suppresses Diabetic Neuropathic Pain by Gating the Intra-epidermal Sprouting of Sensory Axons.

Nuclear Factor-kappaB Gates Nav1.7 Channels in DRG Neurons Via Protein-Protein Interaction.

TNF-α Enhances the Currents of Voltage Gated Sodium Channels in Uninjured Dorsal Root Ganglion Neurons Following Motor Nerve Injury

The P2X7 Receptor is Involved in Diabetic Neuropathic Pain Hypersensitivity Mediated by TRPV1 in the Rat Dorsal Root Ganglion.

Correlative Increasing Expressions of KIF5b and Nav1.7 in DRG Neurons of Rats under Neuropathic Pain Conditions

Silencing P2X7R Alleviates Diabetic Neuropathic Pain Involving TRPV1 Via PKCε/P38MAPK/NF-κB Signaling Pathway in Rats.

Role of transient receptor potential ankyrin 1 in dorsal root ganglion neurons in development of diabetic neuropathic pain in rats

Sodium Channel Nav1.7 Expression is Upregulated in the Dorsal Root Ganglia in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy

Early Over-Expressing of microRNA-145 Effectively Precludes the Development of Neuropathic Mechanical Hyperalgesia via Suppressing Nav1.8 in Diabetic Rats.

Upregulation of transcription factor 4 downregulates Na<sub>v</sub>1.8 expression in DRG neurons and prevents the development of rat inflammatory and neuropathic hypersensitivity